Minding Your Business

Proskauer’s perspective on developments and trends in commercial litigation.

Photo of Lawrence Frank

Lawrence Frank

Lawrence Frank has over fifteen years’ experience practicing patent law in the life sciences.  He applies his scientific training in biochemistry and molecular biology to obtain patent protection for innovators in biotechnology, pharmaceuticals and related fields, and also to advise clients on patent noninfringement and invalidity and in due diligence.  He also applies his knowledge and experience in support of litigation relating to biologics and Orange Book-listed drugs.

Prior to joining Proskauer, Mr. Frank practiced for over ten years at a well-known intellectual property law firm and later formed and ran his own patent law firm with several colleagues.

Subscribe to all posts by Lawrence Frank

CAFC Tightens Enablement Standard for Functional Claiming of Antibodies

In the recent case of Amgen Inc. v. Sanofi, Aventisub LLC, the Federal Circuit affirmed the district court’s invalidation of certain of Amgen’s antibody patent claims, concluding that the claims were not “enable[d]” under 35 U.S.C. § 112. This decision establishes that it is more difficult to satisfy the enablement requirement for antibody claims that … Continue Reading
LexBlog